Ivizia Dry Eye
NDC Package 82095-700-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Ivizia Dry Eye is wash hands well before use.Instill 1 or 2 drops in the affected eye(s) as needed. Marketed by Laboratoires Thea, this product is identified by NDC 82095-700 and is authorized under FDA application part349.

Identification & Billing

NDC Package Code
82095-700-05
Package Description
5 mL in 1 BOTTLE, DROPPER
Product Code
11-Digit Billing Format
82095070005
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Ivizia Dry Eye
Dosage Form
-
Usage Information
Wash hands well before use.Instill 1 or 2 drops in the affected eye(s) as needed. Can be used when wearing contact lenses.*To limit blurriness when using contact lenses: remove contacts, apply drops, then insert contacts.

Regulatory & Marketing

Labeler Name
Laboratoires Thea
FDA Application #
part349
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
11-29-2021
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
Yes

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (82095-700). Click a package code to view its specific billing and regulatory data.

10 mL in 1 BOTTLE, DROPPER
5 mL in 1 BOTTLE, DROPPER

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82095-700-05 identifies a specific commercial package of 5 ml in 1 bottle, dropper of Ivizia Dry Eye, labeled by Laboratoires Thea. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Laboratoires Thea on November 29, 2021. The current certification is valid through December 31, 2022.

How is this Laboratoires Thea product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82095070005. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
82095-700-05
11-Digit CMS (5-4-2)
82095-0700-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.